These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10347984)

  • 1. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study.
    Salomaa V; Matei C; Aleksic N; Sansores-Garcia L; Folsom AR; Juneja H; Chambless LE; Wu KK
    Lancet; 1999 May; 353(9166):1729-34. PubMed ID: 10347984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble thrombomodulin and coronary heart disease.
    Wu KK
    Curr Opin Lipidol; 2003 Aug; 14(4):373-5. PubMed ID: 12865735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study.
    Hwang SJ; Ballantyne CM; Sharrett AR; Smith LC; Davis CE; Gotto AM; Boerwinkle E
    Circulation; 1997 Dec; 96(12):4219-25. PubMed ID: 9416885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sectional association of soluble thrombomodulin with mild peripheral artery disease; the ARIC study. Atherosclerosis Risk in Communities.
    Salomaa V; Matei C; Aleksic N; Sansores-Garcia L; Folsom AR; Juneja H; Park E; Wu KK
    Atherosclerosis; 2001 Aug; 157(2):309-14. PubMed ID: 11472730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble thrombomodulin as predictor of incident coronary heart disease.
    Salomaa V; Wu KK
    Lancet; 1999 Nov; 354(9190):1646-7. PubMed ID: 10560702
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of coagulation factors and inhibitors with carotid artery atherosclerosis. Early results of the Atherosclerosis Risk in Communities (ARIC) Study.
    Wu KK; Folsom AR; Heiss G; Davis CE; Conlan MG; Barnes R
    Ann Epidemiol; 1992 Jul; 2(4):471-80. PubMed ID: 1342298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the Lewis genotype with cardiovascular risk factors and subclinical carotid atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) study.
    Cakir B; Heiss G; Pankow JS; Salomaa V; Sharrett AR; Couper D; Weston BW
    J Intern Med; 2004 Jan; 255(1):40-51. PubMed ID: 14687237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study.
    Folsom AR; Aleksic N; Catellier D; Juneja HS; Wu KK
    Am Heart J; 2002 Aug; 144(2):233-8. PubMed ID: 12177639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities.
    Iribarren C; Folsom AR; Eckfeldt JH; McGovern PG; Nieto FJ
    Ann Epidemiol; 1996 Jul; 6(4):331-40. PubMed ID: 8876844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease.
    Blann AD; Seigneur M; Steiner M; Boisseau MR; McCollum CN
    Eur J Clin Invest; 1997 Nov; 27(11):916-21. PubMed ID: 9395787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble thrombomodulin as a predictor of type 2 diabetes: results from the MONICA/KORA Augsburg case-cohort study, 1984-1998.
    Thorand B; Baumert J; Herder C; Meisinger C; Koenig W
    Diabetologia; 2007 Mar; 50(3):545-8. PubMed ID: 17195062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta3-adrenergic receptor Trp64Arg polymorphism does not predict incident CHD or carotid intima-media thickness in a community-based sample of whites: the ARIC study. Atherosclerosis Risk in Communities.
    Morrison AC; Brancati FL; Folsom AR; Smith L; Boerwinkle E
    Hum Genet; 1999 Oct; 105(4):314-9. PubMed ID: 10543398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between soluble thrombomodulin and intercellular adhesion molecule-1 in predicting risk of coronary heart disease.
    Wu KK; Aleksic N; Ballantyne CM; Ahn C; Juneja H; Boerwinkle E
    Circulation; 2003 Apr; 107(13):1729-32. PubMed ID: 12668515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble thrombomodulin as predictor of incident coronary heart disease.
    Goldstein MR
    Lancet; 1999 Jul; 354(9176):426. PubMed ID: 10437898
    [No Abstract]   [Full Text] [Related]  

  • 15. The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study.
    Agarwala A; Pokharel Y; Saeed A; Sun W; Virani SS; Nambi V; Ndumele C; Shahar E; Heiss G; Boerwinkle E; Konety S; Hoogeveen RC; Ballantyne CM
    Atherosclerosis; 2017 Jul; 262():131-137. PubMed ID: 28554015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating von Willebrand factor antigen II in atherosclerosis: a comparison with von Willebrand factor and soluble thrombomodulin.
    Blann AD; de Romeuf C; Mazurier C; McCollum CN
    Blood Coagul Fibrinolysis; 1998 Apr; 9(3):261-6. PubMed ID: 9663709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study.
    Folsom AR; Chambless LE; Ballantyne CM; Coresh J; Heiss G; Wu KK; Boerwinkle E; Mosley TH; Sorlie P; Diao G; Sharrett AR
    Arch Intern Med; 2006 Jul; 166(13):1368-73. PubMed ID: 16832001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble thrombomodulin in coronary heart disease: lack of an association in the MONICA/KORA case-cohort study.
    Karakas M; Baumert J; Herder C; Rottbauer W; Meisinger C; Koenig W; Thorand B
    J Thromb Haemost; 2011 May; 9(5):1078-80. PubMed ID: 21320279
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study.
    Wang TJ; Nam BH; Wilson PW; Wolf PA; Levy D; Polak JF; D'Agostino RB; O'Donnell CJ
    Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1662-7. PubMed ID: 12377746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of postmenopausal hormone replacement therapy with carotid atherosclerosis and soluble thrombomodulin: the vascular aging (EVA) study. Etude du Vieillissement Artériel.
    Petit L; van Oort FV; Le Gal G; Mennen LI; Alhenc-Gelas M; Touboul PJ; Zureik M; Scarabin PY
    Thromb Res; 2002 Feb; 105(4):291-7. PubMed ID: 12031822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.